Sakar Healthcare
SAKARNSE

Sakar Healthcare

₹802.20-25.40 (3.07%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Livesquawk
Sakar Healthcare Q1 revenue surged 38% YoY to ₹730M vs ₹527M.
Livesquawk
Sakar Healthcare signs 40th deal with Zydus Lifesciences for oncology in GCC, emerging markets. Company filed 23 MAs in EU, gained 5 approvals, developed 21 APIs, and focuses on integration.
Livesquawk
Sakar Healthcare projects FY27 as a key year with stronger exports driving growth. Rising oncology volumes are expected to further support Sakar Healthcare's growth.
Livesquawk
Sakar Healthcare Q4 EBITDA rises to ₹262M, up from ₹157M YoY. EBITDA margin improves to 36.9% from 31.3% YoY.